O36.0925 Maternal care for other rhesus isoimmunization, second trimester, fetus 5

Name of the Condition

• Maternal care for other rhesus isoimmunization, second trimester, fetus 5
• ICD Code: O36.0925

Summary

This condition involves medical care and monitoring provided to a pregnant woman during the second trimester who has developed antibodies against the Rh factor, excluding anti-D antibodies, in a pregnancy with five fetuses. The care focuses on managing potential risks to the fetuses and ensuring maternal health, particularly addressing complications related to Rh incompatibility in a multifetal pregnancy during mid-pregnancy.

Causes

Rhesus isoimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, typically during a previous pregnancy or delivery. This exposure triggers the mother's immune system to produce antibodies that can cross the placenta and attack the red blood cells of Rh-positive fetuses in subsequent pregnancies. In this case, the antibodies are not anti-D but other Rh-specific antibodies.

Risk Factors

• Previous pregnancy with an Rh-positive fetus
• Blood transfusion with Rh-positive blood
• Abdominal trauma during pregnancy
• Invasive prenatal procedures (e.g., amniocentesis)
• Prior miscarriage or ectopic pregnancy involving an Rh-positive fetus

Symptoms

• Often asymptomatic in the mother
• Fetal anemia, jaundice, or hydrops fetalis in severe cases
• Elevated bilirubin levels in the newborn

Diagnosis

Blood typing and antibody screening to detect non-anti-D Rh antibodies. Ultrasound and Doppler studies may assess fetal anemia or hydrops. Amniocentesis or cordocentesis may be used to evaluate fetal blood status in multifetal pregnancies.

Treatment Options

• Close monitoring of maternal antibody levels and fetal well-being
• Intrauterine transfusions for affected fetuses if anemia is severe
• Administration of intravenous immunoglobulin (IVIG) in some cases
• Delivery planning based on fetal and maternal status

Prognosis and Follow-Up

Prognosis depends on the severity of fetal anemia and response to treatment. Regular follow-up with maternal-fetal medicine specialists is essential to monitor antibody levels, fetal growth, and amniotic fluid status. Post-delivery care for newborns may include phototherapy or exchange transfusion if jaundice occurs.

Complications

• Severe fetal anemia or hydrops fetalis
• Preterm labor or delivery
• Increased risk of fetal loss in multifetal pregnancies
• Neonatal jaundice or kernicterus

Lifestyle & Prevention

• Rh-negative women should receive Rh immunoglobulin (RhIg) after events that may cause fetal-maternal bleeding, unless the father is also Rh-negative.
• Avoid unnecessary invasive procedures during pregnancy when possible.
• Prenatal care should include early blood typing and antibody screening.

When to Seek Professional Help

Seek immediate medical attention if experiencing vaginal bleeding, abdominal pain, or reduced fetal movement. Regular prenatal visits are critical for monitoring in multifetal pregnancies with Rh incompatibility.

Tips for Medical Coders

Document the number of fetuses (five) and the trimester (second) clearly. Specify that the isoimmunization involves non-anti-D Rh antibodies. Ensure documentation supports the need for specialized maternal-fetal care in a multifetal pregnancy.